Drugs and money : prices, affordability and cost containment / Edited by M.N.G. Dukes [and four others]

Contributor(s): Publication details: Amsterdam : IOS Press, © 2003Description: VI, 152 pagesContent type:
  • text
Media type:
  • unmediated
Carrier type:
  • volume
ISBN:
  • 1586033344
Online resources:
Scope and content: Content: 1. Scope of the problem. -- 2. Data needed for developing and monitoring policies. -- 3. Policy options for cost containment of pharmaceuticals -- 4. Methods for monitoring and evaluating processes and outcomes. -- 5. Making use of economic evaluation. -- 6. Measures relating to use of drug subsidy lists and to regulation. -- 7. Experiences with budgets. -- 8. Experiences with reference pricing. -- 9. Experiences with patient charges. -- 10. Switching to non-prescription status. -- 11. Experiences with generics. -- 12. Experiences with pharmacy benefit management programmes in the USA. -- 13. Experiences with professional education. -- 14. Providing affordable medicines in transitional countries. -- 15. Access to medicines in low-income countries.
Hello from Record Display Customizations!
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
Cover image Item type Current library Home library Collection Shelving location Call number Materials specified Vol info URL Copy number Status Notes Date due Barcode Item holds Item hold queue priority Course reserves
Book DOH Central Library WHO Publication Section QV 736 DRU 2003 (Browse shelf) Available D0001B001256

Published on behalf of the World Health Organization Regional Office for Europe by IOS Press -- Title page.

Content: 1. Scope of the problem. -- 2. Data needed for developing and monitoring policies. -- 3. Policy options for cost containment of pharmaceuticals -- 4. Methods for monitoring and evaluating processes and outcomes. -- 5. Making use of economic evaluation. -- 6. Measures relating to use of drug subsidy lists and to regulation. -- 7. Experiences with budgets. -- 8. Experiences with reference pricing. -- 9. Experiences with patient charges. -- 10. Switching to non-prescription status. -- 11. Experiences with generics. -- 12. Experiences with pharmacy benefit management programmes in the USA. -- 13. Experiences with professional education. -- 14. Providing affordable medicines in transitional countries. --
15. Access to medicines in low-income countries.

There are no comments on this title.

to post a comment.